Clinical Trials Browser

Phase 1/2 × INDUSTRY × Leukemia, Myelomonocytic, Acute × Clear all

NCT00363974 2009-12-01

Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML

Phase 1/2 Completed

Other hematologic neoplasm

Leukemia, Recurrence, Leukemia, Myelomonocytic, Acute